Ossiam Viatris Inc Transaction History

Ossiam

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$10.05 - $12.02 $119,464 - $142,881	-11,887 Reduced 48.45%	12,646 $134,000
Q1 2024 May 13, 2024	BUY	$11.27 - $13.53 $276,486 - $331,931	24,533 New	24,533 $292,000
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $556,848 - $742,061	60,527 New	60,527 $582,000
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $377,592 - $465,634	-37,949 Reduced 66.82%	18,847 $197,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $907,218 - $1.42 Million	-92,479 Reduced 61.95%	56,796 $618,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $1.51 Million - $1.83 Million	124,655 Added 506.32%	149,275 $2.02 Million
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $435,869 - $542,736	-33,606 Reduced 57.72%	24,620 $346,000
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $1.21 Million - $1.65 Million	-88,866 Reduced 60.42%	58,226 $813,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $2.1 Million - $2.76 Million	147,092 New	147,092 $2.76 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

Stay updated on Ossiam with notifications on news.